Seagen, A Wholly Owned Subsidiary Of Pfizer
Clinical trials sponsored by Seagen, A Wholly Owned Subsidiary Of Pfizer, explained in plain language.
-
New cancer drug trial seeks to tame advanced tumors
Disease control TerminatedThis early-stage study tested a new drug called Felmetatug Vedotin, both alone and combined with pembrolizumab, in people with advanced solid tumors that had spread or could not be removed by surgery. The main goal was to find safe dosage levels and understand side effects for ca…
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Early trial tests new weapon against Tough-to-Treat blood cancers
Disease control TerminatedThis was an early-stage safety study for an experimental drug called PF-08046045, designed for adults with advanced lymphomas that had stopped responding to other treatments. The main goal was to find a safe dose and understand the drug's side effects. The trial was terminated ea…
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC